U.S. FDA Grants Paige Breakthrough Device Designation for Cancer Detection in Breast Lymph Nodes

Paige Lymph Node is recognized by the FDA as a breakthrough device to assist pathologists in the detection of breast cancer metastases in lymph node tissue 

Related Keywords

United States ,Davids Klimstra ,Andy Moye ,Paige Fullfocus ,Drug Administration ,Breakthrough Device Designation ,Paige Lymph Node ,Lymph Node ,Device Designation ,Chief Medical Officer ,Paige Prostate Detect ,Philips Ultrafast ,